Alterations in Immunoreactive Proinsulin and Insulin Clearance Induced by Weight Loss in NIDDM (original) (raw)
Original Articles| July 01 1994
Department of Medicine, The University of Chicago and Pritzker School of Medicine
Chicago, Illinois
Department of Medicine, University of California, San Diego, and Veterans Administration Medical Center
La Jolla, California
Monroe Community Hospital and University of Rochester
Rochester, New York
Search for other works by this author on:
Department of Medicine, The University of Chicago and Pritzker School of Medicine
Chicago, Illinois
Department of Medicine, University of California, San Diego, and Veterans Administration Medical Center
La Jolla, California
Monroe Community Hospital and University of Rochester
Rochester, New York
Search for other works by this author on:
Department of Medicine, The University of Chicago and Pritzker School of Medicine
Chicago, Illinois
Department of Medicine, University of California, San Diego, and Veterans Administration Medical Center
La Jolla, California
Monroe Community Hospital and University of Rochester
Rochester, New York
Search for other works by this author on:
Department of Medicine, The University of Chicago and Pritzker School of Medicine
Chicago, Illinois
Department of Medicine, University of California, San Diego, and Veterans Administration Medical Center
La Jolla, California
Monroe Community Hospital and University of Rochester
Rochester, New York
Search for other works by this author on:
Department of Medicine, The University of Chicago and Pritzker School of Medicine
Chicago, Illinois
Department of Medicine, University of California, San Diego, and Veterans Administration Medical Center
La Jolla, California
Monroe Community Hospital and University of Rochester
Rochester, New York
Search for other works by this author on:
Department of Medicine, The University of Chicago and Pritzker School of Medicine
Chicago, Illinois
Department of Medicine, University of California, San Diego, and Veterans Administration Medical Center
La Jolla, California
Monroe Community Hospital and University of Rochester
Rochester, New York
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Kenneth S. Polonsky, University of Chicago, Department of Medicine, 5841 South Maryland Avenue, MC 1027, Chicago, IL 60637.
Diabetes 1994;43(7):871–877
Subjects with overt non-insulin-dependent diabetes mellitus (NIDDM) were studied in comparison to obese nondiabetic control subjects and patients with subclinical diabetes. Pancreatic insulin secretion rates were measured by deconvolution of peripheral C-peptide over a 24-h period while subjects consumed an isocaloric mixed diet. Subjects were then placed on caloric restriction for at least 6 weeks, during which time body weight fell by at least 10%. Refeeding with solid mixed meals was then resumed for at least 2 weeks until isocaloric intake was attained, and then the meal profiles were repeated. Before weight loss, insulin, C-peptide, and insulin secretion rates were significantly higher in subjects with subclinical diabetes than in the other two groups. Proinsulin concentrations were significantly greater in the two diabetic groups than in control subjects, but, when expressed as a percentage of the total insulin immunoreactivity, the differences were significant only in the group with overt diabetes. Weight loss because of hypocaloric feeding resulted in a significant increase in the rate of clearance of endogenously secreted insulin but did not affect the clearance of C-peptide. In obese subjects and those with subclinical diabetes, weight loss was associated with a reduction in insulin secretion rates, presumably as a result of improvements in insulin sensitivity. In patients with overt diabetes and hyperglycemia, weight loss improved β-cell responsiveness to glucose and was associated with an increase in insulin clearance and a reduction in proinsulin immunoreactivity. contribution of proinsulin to total insulin immunoreactivity, measurement of total insulin-like immunoreactivity alone may provide misleading information in comparing β-cell function before and after weight loss in patients with insulin resistance, glucose intolerance, and diabetes.
This content is only available via PDF.
Copyright © 1994 by the American Diabetes Association
1994
You do not currently have access to this content.
Sign in
Pay-Per-View Access
$40.00